Deals & Cases / Toomas Prangli, Mirell Prosa, Hetti Lump-Kivisaari, Piibe Lehtsaar, Pirkko-Liis Harkmaa, Liisa Maria Kuuskmaa, Andra Grünberg, Olivia Kranich, Kadri Puu, Nauris Grigals, Renāte Purvinska, Andis Burkevics, Marika Grunte, Mindaugas Dominykas Baniulis, Edita Daukšienė, Aurelija Daubaraitė, Jurgita Tekorienė, Raminta Matulytė, Rytė Rečiūnaitė
We are advising BaltCap, the largest private equity manager in the Baltics, on acquiring a 70% share in the leading Baltic automation services provider Hansab Group. Expansion in focus Founded in 1991, Hansab develops and provides security, cash handling, point of sales, parcel handling, queuing, parking and other automation solutions and services to its B2B […]
In cooperation with patent bureau Käosaar, we assisted SA Kunstihoone, a foundation established by the Estonian Artists’ Association and the Ministry of Culture, with the successful registration of its main trademark “Tallinna Kunstihoone”. Descriptive and not distinctive or well-know and with acquired distinctiveness The Estonian Patent Office refused from the registration of the word mark […]
We advised Allfilm, Estonia’s largest film studio, on the production feature film “Last Sentinel”. Top movie The drama/sci-fi/thriller tells the story of a squad of soldiers serving on a military outpost in the middle of an ocean, waiting for relief or the enemy, whichever comes first. ”Last Sentinel” is written by Malachi Smyth and directed […]
We advised TSG Solutions, the European leader in technical services for responsible mobility solutions, on the acquisition of Nordic Gas Solutions, a gas specialist specialising in the design, assembly, installation, and maintenance of high-standard facilities for natural gas and biogas for safe and environmentally sound management. Nordic Gas Solutions is headquartered in Stockholm, Sweden, and […]
We advised AstraZeneca, a global research-based biopharmaceutical company in relation to the company’s participation in a novel public-private partnership to improve lung cancer patient pathway in cooperation and thus contribute jointly to the implementation of the national cancer control plan. New approach National cancer control plan until year 2030 highlights the problem that cancer patients’ […]